The Global
Companion Diagnostics Market is a rapidly growing market. Companion diagnostics
is a part of the in-vitro diagnostics and involves the methods and techniques
that are used for the detection of the viability and safety of the drug components
for the specific patients.
Further some of the major factors that have been
important in the growth of the companion diagnostics market are increasing
costs of the drug discovery and development, rising need for the assessment of
the efficacy and safety of the drugs, distressed need for the specific
medication for rare and chronic disorders, and technological advancements in
the companion diagnostics devices industry.
Global
Companion Diagnostics Market - Competitive Analysis
The Global Companion Diagnostics Industry consists of
number of large and small-scale companies which are involved in the development
of companion diagnostic tools and test. However, there are limited number of
tests, 11 to be precise are approved by the Food & Drug Administration,
USA. The global Companion diagnostic market is majorly dominated by 5 companies
namely Abbott Diagnostics, Agilent Technologies, F. Hoffmann-La Roche AG,
Qiagen N.V., and Thermo Fisher Scientific. These Companies together hold more
than 80% of the market share. Apart from these, there are number of other
companies such as Myriad Genetics, ARUP Laboratories, and Resonance Health
among others.
Get
Exclusive Sample Copy of Premium Research Report @ https://www.marketresearchfuture.com/sample_request/1622 .
Major
Players Business Overview
Dako (Denmark), Qiagen (Germany), f. Hoffmann-la Roche
ltd (Switzerland), Abbott Laboratories, Inc. (US), Ventana Medical Systems,
Inc. (US), Agilent Technologies (US) and Resonance Health (Australia).
Worldwide Companion Diagnostics Market – Segmentations
For the convenience of the report and enhanced
understanding; the report is segmented in to 4 key dynamics
By Types: Comprises Monitoring Tests, Theranostics Tests
among others.
By End Users :
Research Laboratories, Hospital, Medical Institutes and others.
By Applications: Cardiovascular, Cancer Diseases, Central
Nervous Systems and others.
By Regions:
Europe, North America, APAC and Rest of the World.
Worldwide
Companion Diagnostics Market – Geographical Analysis
North America market dominates the global Companion
Diagnostics market with the significant market share. The market is further
expected to reach astronomical amounts growing at a substantial CAGR throughout
the forecast period (2016-2022).
Europe & Asia Pacific is the second & third
largest market respectively in the global Companion Diagnostics market.
Expected to be a fastest growing market Asia pacific region is estimated to
grow rapidly over the projected period.
1. INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE
2. RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH
3. MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4. MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
TOC
Continued…!
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment